Tatva Chintan Pharma Chem Ltd
NSE:TATVA
Wall Street
Price Targets
TATVA Price Targets Summary
Tatva Chintan Pharma Chem Ltd
According to Wall Street analysts, the average 1-year price target for TATVA is 1 533.47 INR with a low forecast of 1 010 INR and a high forecast of 2 073.75 INR.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Tatva Chintan Pharma Chem Ltd
For the last 4 years the compound annual growth rate for Tatva Chintan Pharma Chem Ltd's operating income is -5%. The projected CAGR for the next 2 years is 95%.
Net Income
Forecast
Net Income Estimate
Tatva Chintan Pharma Chem Ltd
For the last 4 years the compound annual growth rate for Tatva Chintan Pharma Chem Ltd's net income is -5%. The projected CAGR for the next 2 years is 106%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TATVA's stock price target?
Price Target
1 533.47
INR
According to Wall Street analysts, the average 1-year price target for TATVA is 1 533.47 INR with a low forecast of 1 010 INR and a high forecast of 2 073.75 INR.
What is Tatva Chintan Pharma Chem Ltd's Revenue forecast?
Projected CAGR
50%
For the last 4 years the compound annual growth rate for Tatva Chintan Pharma Chem Ltd's revenue is 11%. The projected CAGR for the next 2 years is 50%.
What is Tatva Chintan Pharma Chem Ltd's Operating Income forecast?
Projected CAGR
95%
For the last 4 years the compound annual growth rate for Tatva Chintan Pharma Chem Ltd's operating income is -5%. The projected CAGR for the next 2 years is 95%.
What is Tatva Chintan Pharma Chem Ltd's Net Income forecast?
Projected CAGR
106%
For the last 4 years the compound annual growth rate for Tatva Chintan Pharma Chem Ltd's net income is -5%. The projected CAGR for the next 2 years is 106%.